SPRING BANK PHARMACEUTICALS INC has a total of 64 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AXCAN PHARMA INC, BIOIBERICA and LAURAS AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | China | 7 | |
#5 | Republic of Korea | 6 | |
#6 | Taiwan | 4 | |
#7 | Australia | 3 | |
#8 | Canada | 3 | |
#9 | Japan | 3 | |
#10 | Hungary | 2 | |
#11 | United Kingdom | 1 | |
#12 | Hong Kong | 1 | |
#13 | Serbia | 1 | |
#14 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Steroids | |
#5 | Microorganisms | |
#6 | Climate change adaptation technologies | |
#7 | Analysing materials | |
#8 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Iyer Radhakrishnan P | 59 |
#2 | Padmanabhan Seetharamaiyer | 30 |
#3 | Coughlin John Edward | 6 |
#4 | Radhakrishnan P Iyer | 3 |
#5 | Gimi Rayomand H | 3 |
#6 | Iyer Radhakrishnan | 2 |
#7 | John Edward Coughlin | 2 |
#8 | Gimi Rayomand | 1 |
#9 | Baskaran Subramanian | 1 |
#10 | Cleary Dillon | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019071105A1 | Crystalline compounds and methods for the treatment of viral infections | |
TW201821085A | Compositions and methods for the treatment of HBV infection | |
EP3426671A1 | Compounds and compositions for the treatment of infections | |
TW201717968A | Compounds and compositions that induce RIG-I and other pattern recognition receptors | |
CN107922455A | For treating the composition and method of virus infection | |
WO2016164625A1 | Compositions and methods for the treatment of hcv infection | |
TW201709912A | Compositions and methods for the treatment of HBV infection | |
EP2956145A2 | Design of short oligonucleotides as vaccine adjuvants and therapeutic agents | |
CN107973833A | Design as the oligonucleotide analogs of therapeutic agent | |
CN107753499A | For treating the Compounds and methods for of virus infection | |
CN102796155A | Nucleotide and oligonucleotide prodrugs |